Latest filing published 06 Jan 2020 for Neuronetics, Inc., €12k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +97.9%Entry US$4.27 · Close at T+365 US$8.45
- -50.9%Entry US$25.50 · Close at T+365 US$12.52
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Stephen M. Campe: trading record in brief
Stephen M. Campe is a declared insider of Neuronetics, Inc., with filings sourced from SEC (Form 4). In total, 8 filings cover trades dated from 2 July 2018 to 2 January 2020.
The open-market record is one-sided, with 3 purchases worth €192k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 5 share grants.
Half of the purchases are above €37k and half below. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 33% of cases; the median change was -28.8%. Past outcomes like these are no guarantee of what comes next.
On 6 January 2020 came the latest disclosure, a share grant for €12k in Neuronetics, Inc. The last purchase on record was published on 26 November 2019, which is 2,540 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Stephen M. Campe
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,062 shares@ US$4.495.1% of flowCommon StockSEC:0001209191-20-001878:0
- 9,500 shares@ US$4.2615.1% of flowCommon StockSEC:0001209191-19-058031:0Canonical exit: 20 Feb 2020 (T+90)
- 2,500 shares@ US$4.234.0% of flowCommon StockSEC:0001209191-19-058031:1Canonical exit: 23 Feb 2020 (T+90)
- 1,656 shares@ US$8.305.2% of flowCommon StockSEC:0001209191-19-051998:0
- 1,099 shares@ US$12.515.0% of flowCommon StockSEC:0001209191-19-040453:0
- 3,723 sharesCommon StockSEC:0001209191-19-033455:0
- 932 shares@ US$14.755.1% of flowCommon StockSEC:0001209191-19-023358:0
- 10,000 shares@ US$17.0060.5% of flowCommon StockSEC:0001209191-18-041635:0Canonical exit: 30 Sept 2018 (T+90)
8 of 8 declarations